I. Richard Thompson

7.0k citations
24 papers · 2.7k indexed · 1 hit paper · h-index 7
Topics
RNA modifications and cancer (4 papers)Genetics and Neurodevelopmental Disorders (4 papers)Autism Spectrum Disorder Research (4 papers)

In The Last Decade

I. Richard Thompson

23 papers receiving 2.7k citations

Hit Papers

Genomics of Drug Sensitivity in Cancer (GDSC): a resource...2012202620162021201250010001.5k2.0k2.5k

Peers

I. Richard Thompson
Comparison fields: 5 of 113
  • Molecular Biology 1.9k
  • Pulmonary and Respiratory Medicine 899
  • Cancer Research 886
  • Oncology 675
  • Computational Theory and Mathematics 494
Replace Wanjuan Yang with:
Wanjuan Yang United Kingdom
Elena J. Edelman United States
Paul Geeleher United States
Catharina Olsen Belgium
Andrea Bild United States
Patricia Greninger United States
Jianting Sheng United States
David Tamborero Spain
Harry Jubb United Kingdom
Mieke Timmermans Netherlands
I. Richard Thompson relative to Wanjuan Yang United Kingdom Wanjuan Yang's profile →
Citations per field
00.5×1.7×
Wanjuan Yang · 1×
Citations per year

Countries citing papers authored by I. Richard Thompson

Since Specialization
Citations

This map shows the geographic impact of I. Richard Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Richard Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Richard Thompson more than expected).

Fields of papers citing papers by I. Richard Thompson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Richard Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Richard Thompson. The network helps show where I. Richard Thompson may publish in the future.

Co-authorship network of co-authors of I. Richard Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of I. Richard Thompson. A scholar is included among the top collaborators of I. Richard Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Richard Thompson. I. Richard Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 4
3 1
4 5
5 1
6 2
7 1
8 6
9 2
10 5
11 6
12 5
13 11
14 21
15 10
16 22
17 19
18
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cellsbreakdown →
2597
19 0
20 6

About I. Richard Thompson

I. Richard Thompson is a scholar working on Equine, Periodontics and Biological Psychiatry, having authored 24 papers that have together received 2.7k indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Genetics and Neurodevelopmental Disorders (4 papers) and Autism Spectrum Disorder Research (4 papers). The work is most often cited by research in Cancer Research (886 citations), Computational Theory and Mathematics (494 citations) and Molecular Biology (1.9k citations). I. Richard Thompson has collaborated with scholars based in Qatar, United Kingdom and United States. Frequent co-authors include Patricia Greninger, Simon Forbes, Cyril H. Benes, P. Andrew Futreal, Daniel A. Haber, Howard Lightfoot, Michael R. Stratton, Wanjuan Yang, Sridhar Ramaswamy and Ultan McDermott. Their work appears in journals such as Nucleic Acids Research, Bioinformatics and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026